Julius Gräsel

Julius Gräsel is currently the Associate Director Medical Science Liaison Manager for Hemato-Oncology at Eli Lilly and Company, where they also lead the gyn-oncology MSL team. Julius has a strong background in translational medicine, having completed a Ph.D. in Hemato-Oncology at the DKFZ German Cancer Research Center and a Master's in Life Science from the University of Freiburg. They previously worked at Novartis, where they held roles focused on breast cancer and immune oncology, and at AstraZeneca, where they contributed to the establishment of a hematology team in Germany. Julius's research experience includes significant projects at the Walter and Eliza Hall Institute in Melbourne and the Novartis Institutes of Biomedical Research.